Investing.com -- Evoke Pharma (NASDAQ:EVOK) stock surged 134% following the announcement that the company has entered into a definitive agreement to be acquired by QOL Medical, a privately held ...

Investing.com -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) reported record third-quarter revenue of $2.94 billion on ...

LONDON - On Tuesday, Brightstar Lottery PLC (NYSE:BRSL) reported third-quarter adjusted earnings that significantly exceeded analyst expectations, driven by robust same-store sales growth across its ...

Marathon’s refining margins improved significantly year-over-year, with Refining & Marketing margin rising to $17.60 per barrel in Q3 2025, up from $14.63 per barrel in Q3 2024. This improvement ...

GOLDEN, Colo. - Molson Coors Beverage Company (NYSE:TAP) reported third-quarter results that fell short of analyst expectations, with both earnings and revenue declining amid what the company ...

Investing.com -- Jefferies named Broadcom its new Top Pick, saying the chipmaker is “at an inflection point” as demand for custom AI chips surges across hyperscalers. The broker raised its price ...

The luxury carmaker posted Q3 earnings per share (EPS) of 2.14 euros, falling short of analyst expectations of 2.41 euros. Revenue for the period came in at 1.77 billion euros, also below the ...

During the quarter, Graphic Packaging repurchased approximately 1.8 million shares for $39 million, contributing to a year-to-date net share reduction of 2.3%. This article was generated with the ...

Looking ahead, EnPro updated its full-year 2025 guidance to reflect these acquisitions, now projecting revenue growth of 7%-8%, adjusted EBITDA between $275 million and $280 million, and adjusted EPS ...

Investing.com -- UBS in a note dated Tuesday has upgraded its rating on Porsche Automobil Holding SE (ETR:PSHG_p) to “neutral” from “sell” and lifted its price target to €37 from €32, citing updated ...

Investing.com -- Egypt’s Petroleum Ministry announced on Tuesday that it has signed a memorandum of understanding with ExxonMobil to expand natural gas exploration and production activities in the ...

The precision medicine oncology company posted adjusted earnings of $1.33 per share for the quarter ended September 30, with revenue reaching $207.83 million. The revenue primarily stemmed from the ...